Session Type
Meeting
Search Results for Heart Failure
Abstract Number: 63
SHM Converge 2021
Background: The characteristic profiles of lesbian, gay, bisexual, transgender and queer or questioning (LGBTQ) individuals with heart failure are scarce in the literature. This investigation analyzes the demographics of LGBTQ individuals with heart failure and appropriateness of medical therapy. Methods: A multi-center retrospective analysis of LGBTQ individuals with a diagnosis of heart failure was conducted […]
Abstract Number: 114
SHM Converge 2021
Background: Heart failure is expected to increase in prevalence globally.(1) The increased incidence of metabolic disorders coupled with the increase in life expectancy in Singapore has contributed to this trend. Heart failure poses a great burden on patients, caregivers and the healthcare system.Previous European studies have suggested that patients managed by internists differ in baseline […]
Abstract Number: 117
SHM Converge 2021
Background: Serum levels of pro-B-type natriuretic peptide (BNP) and N-terminal (NT) proBNP are measured at admission to assess likelihood of acutely decompensated heart failure (ADHF). Pro-BNP, released by myocardium due to cardiac wall distention, is cleaved into the active BNP and inactive NT-proBNP forms. Elevated NT-proBNP levels on initial presentation are a reliable marker of […]
Abstract Number: 186
SHM Converge 2021
Background: Previous work at our major academic medical center found that compared to White patients, Black and Latinx patients with a primary diagnosis of congestive heart failure (CHF) were significantly less likely to be admitted to our specialized cardiology service rather than our general medicine service (GMS). This work additionally found that CHF patients admitted […]
Abstract Number: 211
SHM Converge 2021
Background: Heart failure (HF) is a common, chronic clinical syndrome often accompanied by episodes of acute decompensation driven by volume overload (1). Reversing this overloaded state is the principal goal in treatment of acute decompensated HF, typically achieved using loop diuretics (2). Despite ubiquitous use of loop diuretics, guidance on initial dosing strategies remains limited […]
Abstract Number: 238
SHM Converge 2021
Background: Heart failure (HF) is a major contributor to hospitalizations. At our institution, we determined that the average length of stay (LOS) for HF admissions was 0.54 days longer than expected compared to similar hospitals nationwide based on a risk-adjusted methodology. A chart review (n=25 patients) revealed that LOS was often extended due to ongoing […]
Abstract Number: 292
SHM Converge 2021
Background: Heart Failure (HF) is an important health care issue given its high prevalence, mortality, and cost of care. By 2030, greater than 8 million Americans will be living with HF. The projected cost will increase to close to 70 billion with the majority of the cost attributed to hospitalization. Despite numerous evidence-based strategies in […]
Abstract Number: 309
SHM Converge 2021
Case Presentation: A 40-year-old woman with a history of anxiety presented with one week of diffuse abdominal pain, associated with constipation, decreased oral intake, nausea, and bilious emesis three times a day. She was admitted to an outside hospital one month prior with similar symptoms and treated for pneumonia. The patient lives alone and denied […]
Abstract Number: 433
SHM Converge 2021
Case Presentation: 66-year-old man with recent diagnosis of heart failure with preserved ejection fraction, atrial fibrillation, and chronic kidney disease presented with worsening shortness of breath. On presentation, he had crackles in the left lower lobe, 1+ pitting edema, and macroglossia. BNP 17,371and creatinine 2.88 (baseline of 2.4). Chest x-ray: mild pulmonary vascular congestion, trace […]
Abstract Number: 515
SHM Converge 2021
Case Presentation: A 48-year-old female with no known medical history presented after a syncopal episode and one week of malaise and fatigue. She was diagnosed with high output heart failure complicating severe pulmonary hypertension. Hemoglobin was 2.7 g/dL with MCV of 50 fL. She denied menorrhagia, melena, hematuria or hematemesis as well as weight loss […]